NCT00513253View on ClinicalTrials.gov

A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

April 30, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Healthy Subjects

Interventions

DRUG

lapatinib

Trial Locations (1)

14202

GSK Investigational Site, Buffalo

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00513253 - A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib | Biotech Hunter | Biotech Hunter